* KOREA Brand : 1) GenBody 2) ASAN PHARAM 3) SD BIOSENSOR 4) BIOCREDIT 5) Wells Bio * Test Type : IgG/IgM Antigen, antibody test * Accuracy rate : 92%~95% * Read result time : 5~10 mins * Package : 25 kit + 1 Reagent / 1 box * Price : FOB Korea 8.5 ~ 10.5 USD / 1 kit * MOQ : 10,000 KIT * Payment Terms : T/T 50% advance and Balance SGS inspection * Product Certificate : KFDA, CE, FDA
* KOREA Brand : 1) OSANG HealthCare 2) SD BIOSENSOR 3) Genematrix * Test Type : RT-PCR * Accuracy rate : 98% * Read result time : One and half hour ~ * Package : 96 test or 100 test / 1 Kit, 1 box * Price : FOB Korea 1,300 ~ 1,650 USD / 100 test * MOQ : 10,000 test * Payment Terms : T/T 50% advance and Balance SGS inspection * Product Certificate : KFDA, CE, FDA
Product Description - COVID-19 Test Kit: PCR Price of product ( USD price or FOB price) - Quantity dependent Product origin - United States Key Specifications/Special Features - FDA and CE: Dry swab: 97% sensitivity; 99% specificity. Lab processed Minimum Order Size and Packaging details - 1000 25 per box, 40 box minimum
Product Description - COVID-19 Test Kit: ANTIGEN (n) Price of product ( USD price or FOB price) - Quantity dependent Product origin - Switzerland Key Specifications/Special Features - CE Mark: 98% sensitivity; 99% specificity (clinical). Approx.10 minute result time Minimum Order Size and Packaging details - 1000 25 per box, 40 box minimum
Product Description - COVID-19 Test Kit: ANTIGEN (s) Price of product ( USD price or FOB price) - Quantity dependent Product origin - Switzerland Key Specifications/Special Features - CE Mark: 97.69% sensitivity; 99.9% specificity (clinical). Approx.10 minute result time Minimum Order Size and Packaging details - 1000 25 per box, 40 box minimum
Product Description - COVID-19 Test Kit: ANTIBODY Price of product ( USD price or FOB price) - Quantity dependent Product origin - Switzerland Key Specifications/Special Features - CE Mark: 96%/92% sensitivity; 100%/100% specificity (clinical). Approx. 10 minute result time Minimum Order Size and Packaging details - 1000 10 per box, 100 box minimum
CareStarfTM COVID-19 ANTIGEN RAPID TESTS Why CareStartTM COVID-19 Live infection 10 minutes Diagnostic Tests dose not require a machine reader! Abbott, Quidel, and BD require readers, that are in short supply. â?¢ EASY TO USE CareStart â?¢ AVAILABILE Rapid Tests on the shelf available products (in inventory) with We offer CareStartTM reliable production and delivery schedules. Abbott, Quidel and BD testing cassettes are in short supply with unreliable availability. â?¢ FDA EUA is currently the only Point-Of-Care rapid antigen test registered authorized under the FDA EUA. CareStart TM CareStarfTM COVID-19 ANTIGEN RAPID TESTS Features Identify individual's current infection status to COVID-19 Fast and easy to use in Point-of-Care setting Qualitatively detect the SARS-CoV-2 nucleocapsid protein Use nasopharyngeal (NP) swab specimens Reliable results only in 1O minutes No special equipment or training required All-in-one package including collection swabs High sensitivity (88.4�°/o) and specificity (100�°/o) Kit Components 20 test devices 20 extraction vials and caps 20 NP swabs 1 positive and 1 negative controls Package insert Quick reference Instructions (QRI)
gg/igm double antibody is 15 minutes out of the accuracy of more than 90% or even up to 98%COVID 19 diagnostic kit is used for the qualitative detection of new coronavirus (2019-nCoV) antibodies in human whole blood, serum and plasma. Coronavirus (CoV) belongs to the order Nestivirus, Coronaviridae, and divided into three genera: �±, �², and �³. The alpha and beta gene are only pathogenic to mammals. The gamma gene mainly causes bird infections. CoV is mainly transmitted through direct contact with secretions or through aerosols and droplets. There is also evidence that it can be transmitted through the fecal-oral route. There have been seven types of human coronavirus (HCoCoV and 2019-nCoV), which are important pathogens of human respiratory tract infection.Among them, the new coronavirus (2019-nCoV) was found for 2019 cases of viral pneumonia in Wuhan. The clinical manifestations are systemic symptoms such as fever, fatigue, dry cough, dyspnea, which can quickly develop into severe pneumonia, respiratory failure, acute Respiratory distress syndrome, toxic shock, multiple organ failure, severe acid-base metabolism disorders and even life-threatening. 2019-nCoV Antibody Diagnostic Kit uses the principle of immunochromatographic method to qualitative detect the coronavirus (2019-nCoV) antibody in human whole blood, serum and plasma. It is used for clinical diagnosis of primary infection or secondary infection of new type of coronavirus infection pneumonia.
When the epidemic is waiting for an opportunity again, to quickly control the spread of the virus, nucleic acid testing has become the only way to go, and it has also attracted attention from all walks of life. However, there are many factors that affect the results of nucleic acid testing, including sample collection location, collection method, storage and transportation process, nucleic acid extraction operation, and so on. Among them, the stability of the sample is a key link. How to quickly inactivate the virus and protect the viral nucleic acid from being degraded, maintaining the stability of the virus sample storage solution has become a top priority. Step 1: Break the shell and eliminate the "combat power" Like other RNA viruses, the results of the new coronavirus are simply composed of a protein shell wrapped in single-stranded nucleic acid-RNA. We can simply think of the RNA of the virus as the "brain" that gives orders, and the protein is the "limbs" that execute orders. The new coronavirus infects the human body and reproduces and causes symptoms. This process is mainly completed by the biologically active protein structure outside the virus. The inactivated virus preservation solution is mainly the virus modified by the nucleic acid extraction lysis solution; it is a powerful protein denaturant that can quickly dissolve the protein and cause the virus structure to be broken. When the clinical sample with the new coronavirus is mixed with the preservation solution, the virus in the sample is affected by the lysis solution, and the protein shell is quickly destroyed, and this damage is irreversible. At this time, the virus has lost its evil "minions" and no longer has the ability to infect people, thus ensuring the safety of contacts during sample transportation and processing. Step 2: Inhibit enzyme activity and escort the "ID card" After the shell is lysed, the RNA of the new coronavirus is free in the preservation solution. As a single-stranded macromolecule, the stability of RNA is not as immobile as double-stranded DNA. The RNase that exists everywhere in the natural environment is the culprit that causes RNA to hydrolyze and break. Therefore, it is generally considered that the viral RNA that has lost its outer shell protection is In addition to the inactivated virus storage solution, the virus preservation solution produced by Desheng also has a non-inactivated virus storage solution. It retains the protein coat of the virus and the viral nucleic acid DNA or RNA at the same time, so that the virus has the integrity of the protein epitope and nucleic acid in vitro. Of course, there is a certain risk of infectivity when operating errors. Long-term storage after sampling needs to keep strictly low temperature. Regardless of the virus preservation solution, we need to strictly operate, store or transport in accordance with the requirements when using it.
Nasal- antigen test kit
With the recurrence of asymptomatic, nucleic acid testing cannot be stopped for a moment. This is not only a protection for everyone, but also a protection for yourself. Speaking of nucleic acid testing, we have to bring up our virus sampling tube again. Its choice also plays a key role. Why use a virus sampling tube? Virus detection is different from conventional biochemical detection. The virus itself is a simple microorganism that must be parasitic in living cells. After sampling, the virus leaves the host cell, and its protein shell and nucleic acid will be quickly degraded in the sampling tube, so the nucleic acid During the test, it is impossible to determine whether the initially collected sample contains the virus, and it is easy to cause false negatives. What are the requirements for an excellent virus sampling tube? 1. In terms of sample effectiveness: The non-inactivated virus preservation solution must maintain the activity of the pathogen's infectious agent. Preferably, it can preserve the activity of the virus at room temperature. The inactivated virus preservation solution needs to inactivate the virus but maintain the nucleic acid of the virus to meet the time from sample sampling to laboratory testing. It is necessary to limit and prevent the reproduction of symbiotic microorganisms to ensure the reliability of diagnostic tests. 2. In terms of safety: Because the virus sampling tubes are basically all infectious substances, and some are highly pathogenic infectious substances, the requirements for packaging containers are very strict, and they need to meet safety and ensure that liquids do not leak during transportation. . So what is the virus preservation solution? Under what circumstances do I need to use a virus preservation solution? The virus preservation solution is a protective liquid medium added to the virus sampling tube to protect the sample after the nasopharyngeal swab is sampled. Normally, nucleic acid PCR cannot be directly performed at the sample collection site during nucleic acid detection. If the sample collected by the swab needs to be transferred and transported, it is necessary to add a virus preservation solution. Why is the virus preservation solution divided into inactivated and non-inactivated? After the virus samples are collected, there is usually no way to test in time at the sample sampling site, so the collected virus swab samples need to be transported, and the virus itself will be quickly lysed outside the body and affect subsequent testing, so when storing and transporting , You need to add a virus preservation solution. For different detection purposes, you need to use different virus preservation solutions and different virus detection experimental conditions, so it is divided into two types of preservation solutions, inactivated and non-inactivated. There are no other microorganisms, causing the virus to decompose after sampling or other influences causing false detections.
Product Description - SARS-CoV-2 Antigen Rapid Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet Covid-19 clinical criteria. Product origin - Turkey / Istanbul Key Specifications/Special Features - vitro diagnostic , Rapid Antigen Test Kit, SARS-CoV-2, Covid 19 Minimum Order Size and Packaging details - 500
SARS-CoV-2 Antigen Rapid Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet Covid-19 clinical criteria. Key Specifications/Special Features - vitro diagnostic , Rapid Antigen Test Kit, SARS-CoV-2, Covid 19, Nasal Rapid Test Kit
Product Description - Covid-19 SARS-CoV-2 Saliva Antigen Rapid Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 Saliva antigen (Ag) in human oropharyngeal (OP), nasal (NS), nasopharygeal (NP) swab, saliva or gargled water specimens from individuals who meet Covid-19 clinical criteria. Product origin - Turkey / Istanbul Minimum Order Size and Packaging details - 500
CORONAVIRUS (SARS COV-2) ANTIGEN DETECTION KIT - Price 2.99 USD ONLY FOB Netherlands Remaining Qty: 60,000 pcs
500k Covid consumer selftests from Acon Flowflex The Acon Biotech Flowflex SARS-CoV-2 antigen test is a self-test for the detection of the COVID-19 antigen in human nasal swabs. The nasal swab only needs to be inserted 2.5 cm deep into the nasal cavity and the test results can be read in 15-30 minutes. This self-test is easy to use for consumers. With the CE0123 status, Acon Flowflex received, these tests are automatically allowed to be sold to consumers throughout Europe.
SARS COV-2 VARIANTS REAL TIME KIT 5 targets. One single reaction tube per sample. Identification of the main SARS Cov-2 variants of concern, UK, South Africa, Brazil, Nigeria, Indian (Delta). Rapid qualitative detection, 45 minutes. Certified CE IVD Full furniture directly.
Manufacturer: Shanghai LiangRun Biomedicine Technology Co.,Ltd. Certificates: CE(EU), MHRA(UK), HSA(Singapore), MDA(Malaysia), TSE(Turkey), DIGEMID(Peru), Luxus Medical(Germany) , FDA(US), EUA(US, Registering) FOB: 10m, 4.5usd
FDA EUA
Made in Canada Health Canada approved CE Mark and ISO certified The product has proven to have 100% Specificity and 96% Sensitivety Stock availabity: 2 Million tests/kit in Canada Production: up to 5 Million tests/kit weekly The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The Rapid Responseâ?¢ COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only. PRODUCT INFORMATION: Product: Rapid Respose Sample: Nasal / Nasopharyngeal secretions Format: Cassette Quantity: 25 Tests/Kit per box Time to result: 15 minutes Storage Condition: 2-30 C/36-86 F Test Principle: Immunochromatographic Assay CONTENTS - Individually packed test devices Extraction Buffer Extraction tube Nozzle with filter Tube stand Individually packed swabs Package Insert
